118 related articles for article (PubMed ID: 16255027)
1. Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease.
Cuenca N; Herrero MT; Angulo A; de Juan E; Martínez-Navarrete GC; López S; Barcia C; Martín-Nieto J
J Comp Neurol; 2005 Dec; 493(2):261-73. PubMed ID: 16255027
[TBL] [Abstract][Full Text] [Related]
2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
3. A rat model of Parkinsonism shows depletion of dopamine in the retina.
Biehlmaier O; Alam M; Schmidt WJ
Neurochem Int; 2007 Jan; 50(1):189-95. PubMed ID: 16962686
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
Nagel F; Bähr M; Dietz GP
Brain Res Bull; 2009 Jun; 79(5):303-9. PubMed ID: 19406215
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
6. Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease.
Dervan AG; Meshul CK; Beales M; McBean GJ; Moore C; Totterdell S; Snyder AK; Meredith GE
Exp Neurol; 2004 Nov; 190(1):145-56. PubMed ID: 15473988
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
[TBL] [Abstract][Full Text] [Related]
9. Minor retinal degeneration in Parkinson's disease.
Huang YM; Yin ZQ
Med Hypotheses; 2011 Feb; 76(2):194-6. PubMed ID: 20933338
[TBL] [Abstract][Full Text] [Related]
10. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
Ohashi S; Mori A; Kurihara N; Mitsumoto Y; Nakai M
Neurosci Lett; 2006 Jun; 401(1-2):183-7. PubMed ID: 16581184
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
12. Meclofenamic acid blocks electrical synapses of retinal AII amacrine and on-cone bipolar cells.
Veruki ML; Hartveit E
J Neurophysiol; 2009 May; 101(5):2339-47. PubMed ID: 19279153
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
Rolland AS; Tandé D; Herrero MT; Luquin MR; Vazquez-Claverie M; Karachi C; Hirsch EC; François C
J Neurochem; 2009 Aug; 110(4):1321-9. PubMed ID: 19527435
[TBL] [Abstract][Full Text] [Related]
14. Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina.
Esteve-Rudd J; Fernández-Sánchez L; Lax P; De Juan E; Martín-Nieto J; Cuenca N
Neurobiol Dis; 2011 Oct; 44(1):102-15. PubMed ID: 21742033
[TBL] [Abstract][Full Text] [Related]
15. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
16. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
[TBL] [Abstract][Full Text] [Related]
17. Expression of brain-derived neurotrophic factor in cholinergic and dopaminergic amacrine cells in the rat retina and the effects of constant light rearing.
Fujieda H; Sasaki H
Exp Eye Res; 2008 Feb; 86(2):335-43. PubMed ID: 18093585
[TBL] [Abstract][Full Text] [Related]
18. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
[TBL] [Abstract][Full Text] [Related]
19. TASK-2 is expressed in proximal neurons in the rat retina.
Zhang XM; Zhong YM; Yang XL
Neuroreport; 2009 Jul; 20(10):946-50. PubMed ID: 19424094
[TBL] [Abstract][Full Text] [Related]
20. Shifting of parvalbumin expression in the rat retina in experimentally induced diabetes.
Park HS; Park SJ; Park SH; Chun MH; Oh SJ
Acta Neuropathol; 2008 Feb; 115(2):241-8. PubMed ID: 17989985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
